Clinical Trial Update: Hemodynamic Effects of Terlipressin and High Dose Octreotide [Phase 4]

View source ↗

Summary

Phase 4 trial evaluated the hemodynamic effects of terlipressin plus high-dose octreotide in gastric and esophageal varices; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric and Esophageal Varices

Drugs mentioned

• Glypressin (terlipressin)
• Sandostatin (Octreotide acetate)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Gastric and Esophageal Varices | Phase 4 | Status: COMPLETED